Psilocybin vs. Psilocin
Filament Health Announces Participation In Project Solace
The Future is Trippy? The FDA Starts Its First-Ever Study on Magic Mushrooms and Psychedelics
Psychedelic Diaries Podcast
Filament Health Announces Closing of $2,500,080 Private Placement
Filament Health Issued Third Patent by United States Patent and Trademark Office
Filament Health Join TheraPsil in World’s Largest Medical Psilocybin Access and Data Project
3 Microdosing Clinical Trials to Keep an Eye On
The FDA to Begin Studies on Magic Mushrooms, a First For the Agency
TraderTV
PsyTechGlobal
Psychedelic Access in Canada: The Special Access Program vs Section 56 Exemption
Patents in Psychedelics Explained
Psychedelics as Medicine: The Current State of Psychedelic Research
